iRay Technology Co Ltd (688301.SS) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · China · ISIN CNE1000042V8

Price
71.26 CNY
Market cap
22.33 bn CNY
P/E (2025)
–
P/S (2025)
9.71
Dividend yield
1.40 %
Net margin
28.76 %
Return on equity (ROE)
–
Return on assets (ROA)
5.16 %

iRay Technology Co Ltd financials

Fiscal year20242025
Revenue1.83 bn CNY2.30 bn CNY
Gross profit916.13 m CNY2.30 bn CNY
Operating income507.16 m CNY694.36 m CNY
EBIT537.10 m CNY697.76 m CNY
Net income465.18 m CNY661.27 m CNY
Diluted EPS – continuing operations2.24 CNY–

Full history since 2015, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About iRay Technology Co Ltd

iRay Group, together with its subsidiaries, researches, develops, produces, sells, and services x-ray system components and micro-display backplanes for use in medical, dental, oncology, veterinary, security, and nondestructive testing applications in China and internationally. The company offers wireless and tethered radiography, mammography, and dynamic/real-time detectors; linear detector arrays; X-ray and micro focus X-ray sources; high voltage generators; radiation detecting materials; software; and other products. It is also involved in the technology and product development; customer service; and investment and management activities. The company exports its products to approximately 80 countries. The company was formerly known as iRay Technology Company Limited and changed its name to iRay Group in February 2025. iRay Group was incorporated in 2011 and is headquartered in Shanghai, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.